Delivery Order SPE2DB24D3013-SPE2DB25FFQRW
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,177.50 on September 11, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units). This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and represents a non-set-aside competitive award. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a $2,355.00 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units). This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The contract involves no set-aside designation, indicating it was competitively awarded through open...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,355.00 firm fixed-price delivery order for Narcan 4 mg nasal spray (2-pack units) on September 15, 2025, with an ultimate completion date of September 16, 2025. The contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,413.00 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (2-count units) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,143.28 for Narcan 4 mg nasal spray (2-count units) on June 18, 2025, with completion targeted for June 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete fulfillment under AmerisourceBergen's broader pharmaceutical supply infrastructure...
- The Defense Logistics Agency awarded a delivery order valued at $2,841.52 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (2-pack units) with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for the supply of Narcan 4 mg nasal spray (2-unit package) with a ceiling value of $11,069.04. This firm fixed-price delivery order is scheduled for completion by September 29, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was utilized for this competitively awarded contract. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Narcan 4 mg nasal spray (2-count packages) with a ceiling value of $1,318.80 and a firm fixed price structure. This delivery order, issued without a set-aside designation, is a competitive award that leverages AmerisourceBergen's established supply chain capabilities. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate...
- This delivery order, awarded August 12, 2025, to AmerisourceBergen Drug Corp for $3,683.24, procures Narcan 4 mg nasal spray (two-pack units) for the Defense Logistics Agency's Medical Supply Chain. The order is non-set-aside and competitively awarded under firm fixed pricing, with performance completed by September 9, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical vendor supporting military and...
- The Defense Logistics Agency awarded a delivery order valued at $2,470.53 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray on August 5, 2025, with completion scheduled for August 6, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQRWDelivery Order
The Defense Logistics Agency awarded a $2,449.20 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 19, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at approximately $1 billion and extends through December 2026. As a pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying a comprehensive portfolio of pharmaceutical products to military and veteran healthcare systems. The company's IDC with the Defense Logistics Agency enables it to provide medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs globally. This particular delivery order for naloxone (Narcan) reflects the company's ongoing role in supplying emergency medical supplies and critical pharmaceuticals to defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/18/25 |